In this study, we demonstrated that NPM1::MLF1 and NPM1::CCDC28A can induce transplantable AML in the mouse transplantation assay, providing experimental evidence that the two novel NPM1-fusions have acquired an oncogenic potential. Here, NPM1 is linked to acute myeloid leukemia.